Compare Cassava Sciences Inc (FLNA) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs NextEra Energy, Inc. — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while NextEra Energy, Inc. trades at $89.12 (market cap $185.83B). The key difference: NextEra Energy, Inc. is far larger — about 3497× Cassava Sciences Inc's market cap, and NextEra Energy, Inc. pays a 2.8% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | NEE | |
|---|---|---|
Market Cap | $53.14M | $185.83B |
Sector | Health | Utilities |
52-Week High | $4.64 | $97.88 |
52-Week Low | $1.09 | $69.77 |
Enterprise Value | -$33.43M | $288.23B |
Dividend Yield | — | 2.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
NextEra Energy (NEE) trades at $89.12, down 0.47% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $103.00. The company reported strong revenue of $27.41 billion in 2025 and a net income margin of 29.37%, though earnings have shown mixed quarterly results. Recent news highlights a proposed combination with Dominion Energy, which could reshape its geographic footprint and data center exposure.
The outlook for NEE remains positive due to robust profitability, a high analyst buy rating (66.66%), and strategic growth initiatives. Key risks include regulatory hurdles from the Dominion deal and rising debt levels, with the debt-to-asset ratio climbing to 47.6% in 2025. Investors should weigh the potential for earnings-driven upside against execution and macroeconomic challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
